Amarin Corp Plc (AMRN)

[MedResCollab]

Can you imagine if the ICER report mentions the potential for REDUCE-IT results to be inflated, and perhaps even carries that somehow into QALY calcs? Could this be a similar set up to pre-AHA, where the stock price was inflated and pumped up on good expectations only? This time it anticipates no AdComm and fabulous ICER report, both currently priced in. What happens if it is let down?

This may prove to be a very interesting month for AMRN.

-MRC